Formulations for cellschedule dependent anticancer agents

Details for Australian Patent Application No. 2004219595 (hide)

Owner Atrix Laboratories, Inc.

Inventors Warren, Stephen L.; Zhou, Mingxing; Dunn, Richard L.; Dadey, Eric J.

Agent Davies Collison Cave

Pub. Number AU-A-2004219595

PCT Pub. Number WO2004/081196

Priority 60/505,124 22.09.03 US; 60/454,100 11.03.03 US

Filing date 11 March 2004

Wipo publication date 23 September 2004

International Classifications

A61F 002/02 Filters - Prostheses implantable into the body

Event Publications

13 October 2005 PCT application entered the National Phase

  PCT publication WO2004/081196 Priority application(s): WO2004/081196

25 November 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(e). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004219599-Methods of evaluating caloric restriction and identifying caloric restriction mimetics

2004219592-Use of Bv8 and/or EG-VEGF to promote hematopoiesis